Form S-1MEF Arcus Biosciences, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Arcus Biosciences (RCUS) IPO Opens 33% Higher
March 15, 2018 10:52 AM EDTToday's IPO for Arcus Biosciences (NYSE: RCUS) opened at $20 after pricing 8,000,000 shares of common stock at a price to the public of $15.00 per share for total gross proceeds of $120,000,000.
The Company has also granted the underwriters a 30-day option to purchase from the... More



